Sectoral Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.34M | Sell |
14,826
-2,512
| -14% | -$210K | 0.94% | 39 |
|
|
2026
Q1 | $1.39M | Buy |
17,338
+88
| +0.5% | +$7.25K | 1.15% | 25 |
|
|
2025
Q4 | $1.47M | Buy |
17,250
+2,250
| +15% | +$185K | 1.18% | 25 |
|
|
2025
Q3 | $1.17M | Hold |
15,000
| – | – | 0.72% | 47 |
|
|
2025
Q2 | $1.17M | Buy |
+15,000
| New | +$1.12M | 0.77% | 43 |
|
|
2025
Q1 | – | Sell |
-7,850
| Closed | -$581K | – | 88 |
|
|
2024
Q4 | $581K | Sell |
7,850
-18,000
| -70% | -$1.26M | 0.39% | 52 |
|
|
2024
Q3 | $1.71M | Buy |
25,850
+10,200
| +65% | +$741K | 1.01% | 27 |
|
|
2024
Q2 | $1.45M | Hold |
15,650
| – | – | 0.59% | 47 |
|
|
2024
Q1 | $1.5M | Sell |
15,650
-6,250
| -29% | -$525K | 0.59% | 53 |
|
|
2023
Q4 | $1.67M | Sell |
21,900
-27,300
| -55% | -$1.9M | 0.72% | 56 |
|
|
2023
Q3 | $3.41M | Buy |
49,200
+13,500
| +38% | +$1.08M | 0.66% | 66 |
|
|
2023
Q2 | $3.37M | Buy |
35,700
+3,800
| +12% | +$330K | 0.56% | 71 |
|
|
2023
Q1 | $2.64M | Hold |
31,900
| – | – | 0.51% | 75 |
|
|
2022
Q4 | $2.38M | Buy |
+31,900
| New | +$2.46M | 0.46% | 75 |
|
|
2022
Q2 | – | Sell |
-15,850
| Closed | -$1.87M | – | 116 |
|
|
2022
Q1 | $1.87M | Buy |
15,850
+4,850
| +44% | +$544K | 0.33% | 83 |
|
|
2021
Q4 | $1.43M | Buy |
+11,000
| New | +$1.28M | 0.21% | 90 |
|
|
2018
Q3 | – | Sell |
-122,580
| Closed | -$5.95M | – | 170 |
|
|
2018
Q2 | $5.95M | Sell |
122,580
-267,297
| -69% | -$12.5M | 0.67% | 46 |
|
|
2018
Q1 | $18.1M | Sell |
389,877
-84,423
| -18% | -$3.67M | 1.99% | 17 |
|
|
2017
Q4 | $17.8M | Buy |
474,300
+76,560
| +19% | +$2.81M | 2.23% | 18 |
|
|
2017
Q3 | $14.5M | Sell |
397,740
-83,400
| -17% | -$3.18M | 1.87% | 27 |
|
|
2017
Q2 | $19M | Sell |
481,140
-120,297
| -20% | -$4.39M | 2.07% | 21 |
|
|
2017
Q1 | $18.9M | Buy |
+601,437
| New | +$18.8M | 2.2% | 20 |
|
|
2016
Q2 | – | Sell |
-331,623
| Closed | -$9.75M | – | 69 |
|
|
2016
Q1 | $9.75M | Sell |
331,623
-419,262
| -56% | -$11.6M | 0.47% | 46 |
|
|
2015
Q4 | $19.8M | Sell |
750,885
-167,805
| -18% | -$4.36M | 0.84% | 33 |
|
|
2015
Q3 | $21.8M | Sell |
918,690
-16,260
| -2% | -$392K | 1% | 28 |
|
|
2015
Q2 | $22.2M | Buy |
+934,950
| New | +$21.1M | 0.93% | 32 |
|
|
2013
Q3 | – | Sell |
-10,551,822
| Closed | -$118M | – | 57 |
|
|
2013
Q2 | $118M | Buy |
+10,551,822
| New | +$125M | 3.49% | 10 |
|
Other funds holding EW
Sectoral Asset Management's EW Position: Q2 2026 in Review
Sectoral Asset Management reduced its Edwards Lifesciences (EW) stake by 14% in Q2 2026, selling an estimated $210K and leaving 14,826 shares worth $1.34M. The position accounts for 0.94% of the portfolio, ranked #39.
Sectoral Asset Management first reported a position in EW in Q2 2013 and has held it in 27 quarters since. The position peaked at $118M in Q2 2013. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Sectoral Asset Management held 14,826 shares of Edwards Lifesciences worth $1.34M as of Q2 2026.
- Sectoral Asset Management sold 2,512 Edwards Lifesciences shares in Q2 2026, an estimated $210K.
- Edwards Lifesciences made up 0.94% of Sectoral Asset Management's portfolio in Q2 2026, its #39 holding.
- Sectoral Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 27 quarters since.
- Sectoral Asset Management's Edwards Lifesciences position peaked at $118M in Q2 2013.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.